<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36742327</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Virus induced dysbiosis promotes type 1 diabetes onset.</ArticleTitle><Pagination><StartPage>1096323</StartPage><MedlinePgn>1096323</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1096323</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1096323</ELocationID><Abstract><AbstractText>Autoimmune disorders are complex diseases of unclear etiology, although evidence suggests that the convergence of genetic susceptibility and environmental factors are critical. In type 1 diabetes (T1D), enterovirus infection and disruption of the intestinal microbiota are two environmental factors that have been independently associated with T1D onset in both humans and animal models. However, the possible interaction between viral infection and the intestinal microbiota remains unknown. Here, we demonstrate that Coxsackievirus B4 (CVB4), an enterovirus that accelerates T1D onset in non-obese diabetic (NOD) mice, induced restructuring of the intestinal microbiome prior to T1D onset. Microbiome restructuring was associated with an eroded mucosal barrier, bacterial translocation to the pancreatic lymph node, and increased circulating and intestinal commensal-reactive antibodies. The CVB4-induced change in community composition was strikingly similar to that of uninfected NOD mice that spontaneously developed diabetes, implying a mutual "diabetogenic" microbiome. Notably, members of the Bifidobacteria and Akkermansia genera emerged as conspicuous members of this diabetogenic microbiome, implicating these taxa, among others, in diabetes onset. Further, fecal microbiome transfer (FMT) of the diabetogenic microbiota from CVB4-infected mice enhanced T1D susceptibility and led to diminished expression of the short chain fatty acid receptor GPR43 and fewer IL-10-expressing regulatory CD4<sup>+</sup> T cells in the intestine of naïve NOD recipients. These findings support an overlap in known environmental risk factors of T1D, and suggest that microbiome disruption and impaired intestinal homeostasis contribute to CVB-enhanced autoreactivity and T1D.</AbstractText><CopyrightInformation>Copyright © 2023 Morse, Simister, Crowe, Horwitz and Osborne.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morse</LastName><ForeName>Zachary J</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simister</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Earth, Ocean, and Atmospheric Sciences, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crowe</LastName><ForeName>Sean A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Earth, Ocean, and Atmospheric Sciences, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horwitz</LastName><ForeName>Marc S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osborne</LastName><ForeName>Lisa C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016688" MajorTopicYN="N">Mice, Inbred NOD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007422" MajorTopicYN="N">Intestines</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">fecal microbiota transplant (FMT)</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword><Keyword MajorTopicYN="N">viral-induced autoimmunity</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36742327</ArticleId><ArticleId IdType="pmc">PMC9892191</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1096323</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ingelfinger JR, Jarcho JA. Increase in the incidence of diabetes and its implications. New Engl J Med (2017) 376(15):1473–4. doi: 10.1056/NEJMe1616575</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe1616575</ArticleId><ArticleId IdType="pubmed">28402766</ArticleId></ArticleIdList></Reference><Reference><Citation>Long AE, Gillespie KM, Rokni S, Bingley PJ, Williams AJK. Rising incidence of type 1 diabetes is associated with altered immunophenotype at diagnosis. Diabetes (2012) 61(3):683–6. doi: 10.2337/db11-0962</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db11-0962</ArticleId><ArticleId IdType="pmc">PMC3282823</ArticleId><ArticleId IdType="pubmed">22315309</ArticleId></ArticleIdList></Reference><Reference><Citation>Redondo MJ, Jeffrey J, Fain PR, Eisenbarth GS, Orban T. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med (2008) 359(26):2849–50. doi: 10.1056/NEJMc0805398</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc0805398</ArticleId><ArticleId IdType="pubmed">19109586</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P, Jojic V, Gao T, Bhattacharya S, Angel CJL, Furman D, et al. . Variation in the human immune system is largely driven by non-heritable influences. Cell (2015) 160(1):37–47. doi: 10.1016/j.cell.2014.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.12.020</ArticleId><ArticleId IdType="pmc">PMC4302727</ArticleId><ArticleId IdType="pubmed">25594173</ArticleId></ArticleIdList></Reference><Reference><Citation>Aw W, Fukuda S. Understanding the role of the gut ecosystem in diabetes mellitus. J Diabetes Investig (2017) 9(1):5–12. doi: 10.1111/jdi.12673</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdi.12673</ArticleId><ArticleId IdType="pmc">PMC5754518</ArticleId><ArticleId IdType="pubmed">28390093</ArticleId></ArticleIdList></Reference><Reference><Citation>Knip M, Simell O. Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 2(7):a007690. doi: 10.1101/cshperspect.a007690</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a007690</ArticleId><ArticleId IdType="pmc">PMC3385937</ArticleId><ArticleId IdType="pubmed">22762021</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Werf N, Kroese FGM, Rozing J, Hillebrands JL. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev (2007) 23(3):169–83. doi: 10.1002/dmrr.695</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.695</ArticleId><ArticleId IdType="pubmed">17103489</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua MP, Alidjinou EK, Hober D. Persistent coxsackievirus b infection and pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol (2022) 18:503–516. doi: 10.1038/s41574-022-00688-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00688-1</ArticleId><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkanen H, Oikarinen S, Nurminen N, Laitinen OH, Huhtala H, Lehtonen J, et al. . Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia (2017) 60(3):424–31. doi: 10.1007/s00125-016-4177-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-016-4177-z</ArticleId><ArticleId IdType="pubmed">28070615</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikarinen M, Tauriainen S, Oikarinen S, Honkanen T, Collin P, Rantala I, et al. . Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes (2012) 61(3):687–91. doi: 10.2337/db11-1157</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db11-1157</ArticleId><ArticleId IdType="pmc">PMC3282798</ArticleId><ArticleId IdType="pubmed">22315304</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikarinen S, Martiskainen M, Tauriainen S, Huhtala H, Ilonen J, Veijola R, et al. . Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes (2011) 60(1):276–9. doi: 10.2337/db10-0186</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db10-0186</ArticleId><ArticleId IdType="pmc">PMC3012181</ArticleId><ArticleId IdType="pubmed">20943747</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Edwin B, Buanes T, Frisk G, Skog O, Anagandula M, et al. . Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes (2015) 64(5):1682–7. doi: 10.2337/db14-1370</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1370</ArticleId><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Stene LC, Oikarinen S, Hyöty H, Barriga KJ, Norris JM, Klingensmith G, et al. . Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the diabetes and autoimmunity study in the young (DAISY). Diabetes (2010) 59(12):3174–80. doi: 10.2337/db10-0866</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db10-0866</ArticleId><ArticleId IdType="pmc">PMC2992780</ArticleId><ArticleId IdType="pubmed">20858685</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbison JE, Roth-Schulze AJ, Giles LC, Tran CD, Ngui KM, Penno MA, et al. . Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study. Pediatr Diabetes (2019) 20(5):574–83. doi: 10.1111/pedi.12865</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pedi.12865</ArticleId><ArticleId IdType="pubmed">31081243</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med (1998) 4(7):781–5. doi: 10.1038/nm0798-781</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0798-781</ArticleId><ArticleId IdType="pubmed">9662368</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest (2002) 109(1):79–87. doi: 10.1172/JCI0211198</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI0211198</ArticleId><ArticleId IdType="pmc">PMC150813</ArticleId><ArticleId IdType="pubmed">11781353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincez PJ, Shanina I, Horwitz MS. Reduced expression of the MDA5 gene IFIH1 prevents autoimmune diabetes. Diabetes (2015) 64(6):2184–93. doi: 10.2337/db14-1223</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1223</ArticleId><ArticleId IdType="pubmed">25591872</ArticleId></ArticleIdList></Reference><Reference><Citation>Morse ZJ, Horwitz MS. Innate viral receptor signaling determines type 1 diabetes onset. Front Endocrinol (Lausanne) (2017) 8:249. doi: 10.3389/fendo.2017.00249</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2017.00249</ArticleId><ArticleId IdType="pmc">PMC5623193</ArticleId><ArticleId IdType="pubmed">29018409</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown EM, Kenny DJ, Xavier RJ. Gut microbiota regulation of T cells during inflammation and autoimmunity. Annu Rev Immunol (2019) 37(1):599–624. doi: 10.1146/annurev-immunol-042718-041841</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041841</ArticleId><ArticleId IdType="pubmed">31026411</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik K, Lynch KF, Wong MC, Tian X, Ross MC, Gibbs RA, et al. . Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat Med (2019) 25(12):1865–72. doi: 10.1038/s41591-019-0667-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0667-0</ArticleId><ArticleId IdType="pmc">PMC6898786</ArticleId><ArticleId IdType="pubmed">31792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullaney JA, Stephens JE, Costello ME, Fong C, Geeling BE, Gavin PG, et al. . Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota. Microbiome (2018) 6:35. doi: 10.1186/s40168-018-0417-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-018-0417-4</ArticleId><ArticleId IdType="pmc">PMC5816355</ArticleId><ArticleId IdType="pubmed">29454391</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariño E, Richards JL, McLeod KH, Stanley D, Yap YA, Knight J, et al. . Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol (2017) 18(5):552–62. doi: 10.1038/ni.3713</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3713</ArticleId><ArticleId IdType="pubmed">28346408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao G, Vatanen T, Droit L, Park A, Kostic AD, Poon TW, et al. . Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children. Proc Natl Acad Sci (2017) 114(30):E6166-E6175. doi: 10.1073/pnas.1706359114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1706359114</ArticleId><ArticleId IdType="pmc">PMC5544325</ArticleId><ArticleId IdType="pubmed">28696303</ArticleId></ArticleIdList></Reference><Reference><Citation>Filyk HA, Osborne LC. The multibiome: The intestinal ecosystem’s influence on immune homeostasis, health, and disease. EBioMedicine (2016) 13:46–54. doi: 10.1016/j.ebiom.2016.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2016.10.007</ArticleId><ArticleId IdType="pmc">PMC5264270</ArticleId><ArticleId IdType="pubmed">27863931</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman M, Kua L, Tanca A, Pala M, Palomba A, Tanes C, et al. . Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny. Proc Natl Acad Sci (2017) 114(36):9671–6. doi: 10.1073/pnas.1712280114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1712280114</ArticleId><ArticleId IdType="pmc">PMC5594701</ArticleId><ArticleId IdType="pubmed">28831005</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedrick S, Sundaresh B, Huang Q, Brady C, Yoo T, Cronin C, et al. . The role of gut microbiota and environmental factors in type 1 diabetes pathogenesis. Front Endocrinol (2020) 11. doi: 10.3389/fendo.2020.00078</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00078</ArticleId><ArticleId IdType="pmc">PMC7057241</ArticleId><ArticleId IdType="pubmed">32174888</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatanen T, Franzosa EA, Schwager R, Tripathi S, Arthur TD, Vehik K, et al. . The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature (2018) 562(7728):589–94. doi: 10.1038/s41586-018-0620-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0620-2</ArticleId><ArticleId IdType="pmc">PMC6296767</ArticleId><ArticleId IdType="pubmed">30356183</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Gagliani N, Ishigame H, Huber S, Zhu S, Esplugues E, et al. . Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development. Proc Natl Acad Sci USA (2017) 114(39):10443–8. doi: 10.1073/pnas.1705599114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1705599114</ArticleId><ArticleId IdType="pmc">PMC5625908</ArticleId><ArticleId IdType="pubmed">28894001</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson JA, Tai N, Ekanayake-Alper DK, Peng J, Hu Y, Hager K, et al. . Norovirus changes susceptibility to type 1 diabetes by altering intestinal microbiota and immune cell functions. Front Immunol (2019) 10(2654). doi: 10.3389/fimmu.2019.02654</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02654</ArticleId><ArticleId IdType="pmc">PMC6863139</ArticleId><ArticleId IdType="pubmed">31798584</ArticleId></ArticleIdList></Reference><Reference><Citation>Turley SJ, Lee JW, Dutton-Swain N, Mathis D, Benoist C. Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci U S A (2005) 102(49):17729–33. doi: 10.1073/pnas.0509006102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0509006102</ArticleId><ArticleId IdType="pmc">PMC1308925</ArticleId><ArticleId IdType="pubmed">16317068</ArticleId></ArticleIdList></Reference><Reference><Citation>Pöysti S, Toivonen R, Takeda A, Silojärvi S, Yatkin E, Miyasaka M, et al. . Infection with the enteric pathogen c. rodentium promotes islet-specific autoimmunity by activating a lymphatic route from the gut to pancreatic lymph node. Mucosal Immunol (2022) 15(3):471–9. doi: 10.1038/s41385-022-00490-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-022-00490-2</ArticleId><ArticleId IdType="pmc">PMC9038524</ArticleId><ArticleId IdType="pubmed">35140345</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrows MP, Volchkov P, Kobayashi KS, Chervonsky AV. Microbiota regulates type 1 diabetes through toll-like receptors. Proc Natl Acad Sci USA (2015) 112(32):9973–7. doi: 10.1073/pnas.1508740112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1508740112</ArticleId><ArticleId IdType="pmc">PMC4538618</ArticleId><ArticleId IdType="pubmed">26216961</ArticleId></ArticleIdList></Reference><Reference><Citation>Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, et al. . Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med (2013) 5(193):193ra91. doi: 10.1126/scitranslmed.3006438</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3006438</ArticleId><ArticleId IdType="pmc">PMC4094294</ArticleId><ArticleId IdType="pubmed">23843452</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue T, Nakayama J, Moriya K, Kawaratani H, Momoda R, Ito K, et al. . Gut dysbiosis associated with hepatitis c virus infection. Clin Infect Dis (2018) 67(6):869–77. doi: 10.1093/cid/ciy205</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy205</ArticleId><ArticleId IdType="pubmed">29718124</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz S, Mazel-Sanchez B, Kandasamy M, Manicassamy B, Schmolke M. Influenza a virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis. Microbiome (2018) 6(1):9. doi: 10.1186/s40168-017-0386-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0386-z</ArticleId><ArticleId IdType="pmc">PMC5763955</ArticleId><ArticleId IdType="pubmed">29321057</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Sun L, Zhang S, Zhao X, Gang X, Wang G. Evaluating the causal role of gut microbiota in type 1 diabetes and its possible pathogenic mechanisms. Front Endocrinol (2020) 11(125). doi: 10.3389/fendo.2020.00125</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00125</ArticleId><ArticleId IdType="pmc">PMC7105744</ArticleId><ArticleId IdType="pubmed">32265832</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkanani AK, Hara N, Gottlieb PA, Ir D, Robertson CE, Wagner BD, et al. . Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes (2015) 64(10):3510–20. doi: 10.2337/db14-1847</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1847</ArticleId><ArticleId IdType="pmc">PMC4587635</ArticleId><ArticleId IdType="pubmed">26068542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostic AD, Gevers D, Siljander H, Vatanen T, Hyötyläinen T, Hämäläinen AM, et al. . The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe (2015) 17(2):260–73. doi: 10.1016/j.chom.2015.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2015.01.001</ArticleId><ArticleId IdType="pmc">PMC4689191</ArticleId><ArticleId IdType="pubmed">25662751</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorini C, Cosorich I, Lo Conte M, De Giorgi L, Facciotti F, Lucianò R, et al. . Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes. Proc Natl Acad Sci (2019) 116(30):15140–9. doi: 10.1073/pnas.1814558116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1814558116</ArticleId><ArticleId IdType="pmc">PMC6660755</ArticleId><ArticleId IdType="pubmed">31182588</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng MY, Cisalpino D, Varadarajan S, Hellman J, Warren HS, Cascalho M, et al. . Gut microbiota-induced immunoglobulin G controls systemic infection by symbiotic bacteria and pathogens. Immunity (2016) 44(3):647–58. doi: 10.1016/j.immuni.2016.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.02.006</ArticleId><ArticleId IdType="pmc">PMC4794373</ArticleId><ArticleId IdType="pubmed">26944199</ArticleId></ArticleIdList></Reference><Reference><Citation>Paun A, Yau C, Meshkibaf S, Daigneault MC, Marandi L, Mortin-Toth S, et al. . Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children. Sci Immunol (2019) 4(32):eaau8125. doi: 10.1126/sciimmunol.aau8125</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aau8125</ArticleId><ArticleId IdType="pmc">PMC7380548</ArticleId><ArticleId IdType="pubmed">30709843</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Pearson JA, Peng J, Hu Y, Sha S, Xing Y, et al. . Gut microbial metabolites alter IgA immunity in type 1 diabetes. JCI Insight (2020) 5(10):e135718. doi: 10.1172/jci.insight.135718</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.135718</ArticleId><ArticleId IdType="pmc">PMC7259536</ArticleId><ArticleId IdType="pubmed">32298241</ArticleId></ArticleIdList></Reference><Reference><Citation>Leïla AO, Hela J, Famara S, Nedia JB, Sabrine H, Didier H, et al. . Evaluation of contamination risks with coxsackievirus B4 E2 in Swiss albino mice stools. Curr Microbiol (2018) 75(1):32–9. doi: 10.1007/s00284-017-1347-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-017-1347-2</ArticleId><ArticleId IdType="pubmed">28856411</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, et al. . The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science (2013) 341(6145):569–73. doi: 10.1126/science.1241165</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1241165</ArticleId><ArticleId IdType="pmc">PMC3807819</ArticleId><ArticleId IdType="pubmed">23828891</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Wu W, Chen L, Yang W, Huang X, Ma C, et al. . Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat Commun (2018) 9(1):3555. doi: 10.1038/s41467-018-05901-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05901-2</ArticleId><ArticleId IdType="pmc">PMC6120873</ArticleId><ArticleId IdType="pubmed">30177845</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon MC, Reinbeck AL, Wessel C, Heindirk J, Jelenik T, Kaul K, et al. . Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice. J Biol Chem (2020) 295(4):969–80. doi: 10.1016/S0021-9258(17)49908-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)49908-X</ArticleId><ArticleId IdType="pmc">PMC6983849</ArticleId><ArticleId IdType="pubmed">31822562</ArticleId></ArticleIdList></Reference><Reference><Citation>Sioofy-Khojine AB, Lehtonen J, Nurminen N, Laitinen OH, Oikarinen S, Huhtala H, et al. . Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes. Diabetologia (2018) 61(5):1193–202. doi: 10.1007/s00125-018-4561-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-018-4561-y</ArticleId><ArticleId IdType="pubmed">29404673</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Kirby J, Reilly CM, Luo XM. Leaky gut as a danger signal for autoimmune diseases. Front Immunol (2017) 8. doi: 10.3389/fimmu.2017.00598</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00598</ArticleId><ArticleId IdType="pmc">PMC5440529</ArticleId><ArticleId IdType="pubmed">28588585</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, et al. . Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia (2006) 49(12):2824–7. doi: 10.1007/s00125-006-0465-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-006-0465-3</ArticleId><ArticleId IdType="pubmed">17028899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofi MH, Johnson BM, Gudi RR, Jolly A, Gaudreau MC, Vasu C. Polysaccharide a-dependent opposing effects of mucosal and systemic exposures to human gut commensal bacteroides fragilis in type 1 diabetes. Diabetes (2019) 68(10):1975–89. doi: 10.2337/db19-0211</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db19-0211</ArticleId><ArticleId IdType="pmc">PMC6754247</ArticleId><ArticleId IdType="pubmed">31311801</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda MCG, Oliveira RP, Torres L, Aguiar SLF, Pinheiro-Rosa N, Lemos L, et al. . Frontline science: Abnormalities in the gut mucosa of non-obese diabetic mice precede the onset of type 1 diabetes. J Leukoc Biol (2019) 106(3):513–29. doi: 10.1002/JLB.3HI0119-024RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3HI0119-024RR</ArticleId><ArticleId IdType="pubmed">31313381</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa FRC, Françozo MCS, de Oliveira GG, Ignacio A, Castoldi A, Zamboni DS, et al. . Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. J Exp Med (2016) 213(7):1223–39. doi: 10.1084/jem.20150744</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20150744</ArticleId><ArticleId IdType="pmc">PMC4925011</ArticleId><ArticleId IdType="pubmed">27325889</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdellatif AM, Jensen Smith H, Harms RZ, Sarvetnick NE. Human islet response to selected type 1 diabetes-associated bacteria: A transcriptome-based study. Front Immunol (2019) 10:2623. doi: 10.3389/fimmu.2019.02623</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02623</ArticleId><ArticleId IdType="pmc">PMC6857727</ArticleId><ArticleId IdType="pubmed">31781116</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai N, Peng J, Liu F, Gulden E, Hu Y, Zhang X, et al. . Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice. J Exp Med (2016) 213(10):2129–46. doi: 10.1084/jem.20160526</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160526</ArticleId><ArticleId IdType="pmc">PMC5030808</ArticleId><ArticleId IdType="pubmed">27621416</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers MA, Hettiarachchi KD, Ludeman JP, Wilson AJ, Wilson CR, Zimmet PZ. Dietary microbial toxins and type 1 diabetes. Ann N Y Acad Sci (2003) 1005:418–22. doi: 10.1196/annals.1288.071</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1288.071</ArticleId><ArticleId IdType="pubmed">14679104</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis AM, Round JL. Microbiota-antibody interactions that regulate gut homeostasis. Cell Host Microbe (2021) 29(3):334–46. doi: 10.1016/j.chom.2021.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.02.009</ArticleId><ArticleId IdType="pmc">PMC7990058</ArticleId><ArticleId IdType="pubmed">33705705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira RC, Pan-Hammarström Q, Graham RR, Gateva V, Fontán G, Lee AT, et al. . Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat Genet (2010) 42(9):777–80. doi: 10.1038/ng.644</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.644</ArticleId><ArticleId IdType="pubmed">20694011</ArticleId></ArticleIdList></Reference><Reference><Citation>Talja I, Kubo AL, Veijola R, Knip M, Simell O, Ilonen J, et al. . Antibodies to lactobacilli and bifidobacteria in young children with different propensity to develop islet autoimmunity. J Immunol Res (2014) 2014:325938. doi: 10.1155/2014/325938</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/325938</ArticleId><ArticleId IdType="pmc">PMC3987879</ArticleId><ArticleId IdType="pubmed">24741589</ArticleId></ArticleIdList></Reference><Reference><Citation>Krych Ł, Nielsen DS, Hansen AK, Hansen CHF. Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice. Gut Microbes (2015) 6(2):101–9. doi: 10.1080/19490976.2015.1011876</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2015.1011876</ArticleId><ArticleId IdType="pmc">PMC4615729</ArticleId><ArticleId IdType="pubmed">25648687</ArticleId></ArticleIdList></Reference><Reference><Citation>Geva-Zatorsky N, Sefik E, Kua L, Pasman L, Tan TG, Ortiz-Lopez A, et al. . Mining the human gut microbiota for immunomodulatory organisms. Cell (2017) 168(5):928–943.e11. doi: 10.1016/j.cell.2017.01.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.01.022</ArticleId><ArticleId IdType="pmc">PMC7774263</ArticleId><ArticleId IdType="pubmed">28215708</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatanen T, Kostic AD, d’Hennezel E, Siljander H, Franzosa EA, Yassour M, et al. . Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell (2016) 165(4):842–53. doi: 10.1016/j.cell.2016.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.007</ArticleId><ArticleId IdType="pmc">PMC4950857</ArticleId><ArticleId IdType="pubmed">27133167</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Yu T, Huang X, Bilotta AJ, Xu L, Lu Y, et al. . Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun (2020) 11(1):4457. doi: 10.1038/s41467-020-18262-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18262-6</ArticleId><ArticleId IdType="pmc">PMC7478978</ArticleId><ArticleId IdType="pubmed">32901017</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hee B, Wells JM. Microbial regulation of host physiology by short-chain fatty acids. Trends Microbiol (2021) 29(8):700–12. doi: 10.1016/j.tim.2021.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.02.001</ArticleId><ArticleId IdType="pubmed">33674141</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob N, Jaiswal S, Maheshwari D, Nallabelli N, Khatri N, Bhatia A, et al. . Butyrate induced tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes. Sci Rep (2020) 10(1):19120. doi: 10.1038/s41598-020-76109-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76109-y</ArticleId><ArticleId IdType="pmc">PMC7644709</ArticleId><ArticleId IdType="pubmed">33154424</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaikova E, Walsh DA, Stilwell CP, Mohn WW, Tortell PD, Hallam SJ. Microbial community dynamics in a seasonally anoxic fjord: Saanich inlet, British Columbia. Environ Microbiol (2010) 12(1):172–91. doi: 10.1111/j.1462-2920.2009.02058.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-2920.2009.02058.x</ArticleId><ArticleId IdType="pubmed">19788414</ArticleId></ArticleIdList></Reference><Reference><Citation>Gueimonde M, Tölkkö S, Korpimäki T, Salminen S. New real-time quantitative PCR procedure for quantification of bifidobacteria in human fecal samples. Appl Environ Microbiol (2004) 70(7):4165–9. doi: 10.1128/AEM.70.7.4165-4169.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.70.7.4165-4169.2004</ArticleId><ArticleId IdType="pmc">PMC444799</ArticleId><ArticleId IdType="pubmed">15240297</ArticleId></ArticleIdList></Reference><Reference><Citation>Apprill A, McNally S, Parsons R, Weber L. Minor revision to V4 region SSU rRNA 806R gene primer greatly increases detection of SAR11 bacterioplankton. Aquat Microb Ecol (2015) 75(2):129–37. doi: 10.3354/ame01753</Citation><ArticleIdList><ArticleId IdType="doi">10.3354/ame01753</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, et al. . Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci (2011) 108:4516–22. doi: 10.1073/pnas.1000080107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000080107</ArticleId><ArticleId IdType="pmc">PMC3063599</ArticleId><ArticleId IdType="pubmed">20534432</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. . Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol (2019) 37(8):852–7. doi: 10.1038/s41587-019-0209-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0209-9</ArticleId><ArticleId IdType="pmc">PMC7015180</ArticleId><ArticleId IdType="pubmed">31341288</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from illumina amplicon data. Nat Methods (2016) 13(7):581–3. doi: 10.1038/nmeth.3869</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3869</ArticleId><ArticleId IdType="pmc">PMC4927377</ArticleId><ArticleId IdType="pubmed">27214047</ArticleId></ArticleIdList></Reference><Reference><Citation>Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. . The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res (2013) 41(Database issue):D590–6. doi: 10.1093/nar/gks1219</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1219</ArticleId><ArticleId IdType="pmc">PMC3531112</ArticleId><ArticleId IdType="pubmed">23193283</ArticleId></ArticleIdList></Reference><Reference><Citation>Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. . Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol (2009) 75(23):7537–41. doi: 10.1128/AEM.01541-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.01541-09</ArticleId><ArticleId IdType="pmc">PMC2786419</ArticleId><ArticleId IdType="pubmed">19801464</ArticleId></ArticleIdList></Reference><Reference><Citation>Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. . Metagenomic biomarker discovery and explanation. Genome Biol (2011) 12(6):R60. doi: 10.1186/gb-2011-12-6-r60</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2011-12-6-r60</ArticleId><ArticleId IdType="pmc">PMC3218848</ArticleId><ArticleId IdType="pubmed">21702898</ArticleId></ArticleIdList></Reference><Reference><Citation>Staley C, Kaiser T, Beura LK, Hamilton MJ, Weingarden AR, Bobr A, et al. . Stable engraftment of human microbiota into mice with a single oral gavage following antibiotic conditioning. Microbiome (2017) 5(1):87. doi: 10.1186/s40168-017-0306-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0306-2</ArticleId><ArticleId IdType="pmc">PMC5537947</ArticleId><ArticleId IdType="pubmed">28760163</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>